The grant will support Burdick’s research project “Identification of E-selectin Ligands on Breast Cancer Cells.”
“Hopefully, this will lay the groundwork for bigger and better things,” said Burdick, who recently completed her first year at OhioUniversity.
Ohio Cancer Research Associates is a Columbus-based nonprofit organization. Since its establishment in 1982, Ohio Cancer Research Associates has awarded more than $5.7 million for cancer research. That, in turn, has led to more than $80.3 million in additional funding from other sources for the projects, according to organization’s Web site.
The grant is Burdick’s first as an independent investigator. “These institutions have faith in the research plan that I’m proposing,” she said. “That feels pretty good.”
Burdick’s research team will be looking for molecules that could be used by breast cancer cells when metastasizing to the lung or bone marrow.
“If we find these molecules, then we potentially have targets for diagnostic developments, as well as therapeutics,” Burdick said.